Crescent Biopharma拟于2027年一季度公布Ascend试验初步单药数据,涵盖一线NSCLC队列抗肿瘤缓解结果

美股速递
Oct 16

Crescent Biopharma计划在2027年第一季度公布Ascend研究的初步单药治疗数据,其中将包含一线非小细胞肺癌(NSCLC)队列的抗肿瘤缓解情况。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10